Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose in Parkinson's disease
IRCT20181022041407N10Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of trehalose in Parkinson's disease (PD), sponsored by Mashhad University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
trehalose
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20181022041407N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181022041407N10.